5-(pyridin-2-yl)-2,4-dihydro-3H-pyrazol-3-one | 72764-97-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 5-(pyridin-2-yl)-2,4-dihydro-3H-pyrazol-3-one
• 英文别名: 5-pyridin-2-yl-1,2-dihydro-pyrazol-3-one；3-(2-pyridyl)-4, 5-dihydropyrazol-5-one；3-(pyridin-2-yl)-4,5-dihydropyrazol-5-one；3-pyridin-2-yl-1,4-dihydropyrazol-5-one
• CAS: 72764-97-7
• 化学式: C₈H₇N₃O
• 分子量: 161.163
• InChiKey: KDMXPHUQHISFDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-(pyridin-2-yl)-2,4-dihydro-3H-pyrazol-3-one 、 Dinitrooxythallanyl nitrate 以80%的产率得到
  参考文献：
  名称：

  COSSY J.; PETE J.-P., BULL. SOC. CHIM. FRANCE, 1979, PART 2, NO 9-10, 559-567

  摘要：

  DOI：
• 作为产物：
  描述：

  3-氧代-3-(2-吡啶)丙酸甲酯 在 肼 作用下， 以 乙醇 为溶剂， 生成 5-(pyridin-2-yl)-2,4-dihydro-3H-pyrazol-3-one
  参考文献：
  名称：

  3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3β

  摘要：

  A series of 3-aryl-4-(arylhydrazono)-1H-pyrazol-5-one inhibitors of GSK3 beta was developed from a low molecular weight, highly ligand efficient screening hit 1. Hit-to-lead optimization led to a number of highly potent inhibitors, while maintaining the high ligand efficiency of the screening hit. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.01.072

文献信息

• [EN] 6-AMINO-2,4-DIHYDROPYRANO [2,3-C] PYRAZOLES AND METHODS OF USE<br/>[FR] 6-AMINO-2,4-DIHYDROPYRANO [2,3-C] PYRAZOLES ET PROCÉDÉS D'UTILISATION
  申请人：PURDUE RESEARCH FOUNDATION

  公开号：WO2018183587A1

  公开（公告）日：2018-10-04

  The present invention generally relates to 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles as a ubiquitin specific protease 7 (USP7) inhibitor useful for the treatment of diseases mediated by malfunction of USP7, such as inflammation, cancer, and immunological disorders. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases mediated by malfunction of USP7, in mammals using compounds disclosed herein.

  本发明通常涉及6-氨基-2,4-二氢吡喃并[2,3-c]吡唑醇作为一种泛素特异性蛋白酶7（USP7）抑制剂，用于治疗由USP7功能失调介导的疾病，如炎症、癌症和免疫性疾病。本文所述的发明还涉及使用本文披露的化合物在哺乳动物中治疗由USP7功能失调介导的疾病的药物组合物和方法。
• 4, 5-dihydropyrazole-5-thione derivatives and miticides comprising the
  申请人：Otsuka Kagaku Kabushiki Kaisha

  公开号：US05639776A1

  公开（公告）日：1997-06-17

  The object of the present invention is to provide a novel 4, 5-dihydropyrazole-5-thione derivative which exerts remarkably potent miticidal activity. The 4, 5-dihydropyrazole-5-thione derivative of the present invention is represented by the general formula ##STR1## wherein R.sup.1 represents a straight- or branched-chain alkyl group having 1 to 12 carbon atoms or the like; R.sup.2 and R.sup.3 represent a lower alkyl group or the like; X represents a halogen atom or the like, n is 0 or an integer of 1 to 3; and A represents .paren open-st.C.paren close-st. or .paren open-st.N.paren close-st..

  本发明的目的是提供一种新颖的4,5-二氢吡唑-5-硫酮衍生物，具有显著的杀螨活性。本发明的4,5-二氢吡唑-5-硫酮衍生物由下述一般式表示： 其中R.sup.1表示具有1至12个碳原子的直链或支链烷基基团或类似物；R.sup.2和R.sup.3表示较低的烷基基团或类似物；X表示卤素原子或类似物，n为0或1至3的整数；A表示 .paren open-st.C.paren close-st. 或 .paren open-st.N.paren close-st.。
• 4,5-DIHYDROPYRAZOLE-5-THIONE DERIVATIVES AND ACARICIDE CONTAINING THE SAME
  申请人：OTSUKA KAGAKU KABUSHIKI KAISHA

  公开号：EP0751130A1

  公开（公告）日：1997-01-02

  The object of the present invention is to provide a novel 4, 5-dihydropyrazole-5-thione derivative which exerts remarkably potent miticidal activity. The 4, 5-dihydropyrazole-5-thione derivative of the present invention is represented by the general formula wherein R1 represents a straight- or branched-chain alkyl group having 1 to 12 carbon atoms or the like; R2 and R3 represent a lower alkyl group or the like; X represents a halogen atom or the like, n is 0 or an integer of 1 to 3; and A represents (̵C or (̵N.

  本发明的目的是提供一种新型的 4，5-二氢吡唑-5-硫酮衍生物，它具有显著的杀丝虫活性。本发明的 4，5-二氢吡唑-5-硫酮衍生物由通式表示 其中 R1 代表具有 1 至 12 个碳原子的直链或支链烷基或类似物；R2 和 R3 代表低级烷基或类似物；X 代表卤素原子或类似物；n 为 0 或 1 至 3 的整数；以及 A 代表 (̵C 或 (̵N.
• 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles and methods of use
  申请人：Purdue Research Foundation

  公开号：US10980781B2

  公开（公告）日：2021-04-20

  The present invention generally relates to 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles as a ubiquitin specific protease 7(USP7) inhibitor useful for the treatment of diseases mediated by malfunction of USP7, such as inflammation, cancer, and immunological disorders. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases mediated by malfunction of USP7, in mammals using compounds disclosed herein.

  本发明一般涉及作为泛素特异性蛋白酶7（USP7）抑制剂的6-氨基-2,4-二氢吡喃并[2,3-c]吡唑，可用于治疗由USP7功能失调介导的疾病，如炎症、癌症和免疫紊乱。本文所述的发明还涉及使用本文公开的化合物治疗哺乳动物中由 USP7 功能失常介导的疾病的药物组合物和方法。
• 6-AMINO-2,4-DIHYDROPYRANO [2,3-C] PYRAZOLES AND METHODS OF USE
  申请人：Purdue Research Foundation

  公开号：US20200078336A1

  公开（公告）日：2020-03-12

  The present invention generally relates to 6-amino-2,4-dihydropyrano [2,3-c] pyrazoles as a ubiquitin specific protease 7 (USP7) inhibitor useful for the treatment of diseases mediated by malfunction of USP7, such as inflammation, cancer, and immunological disorders. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases mediated by malfunction of USP7, in mammals using compounds disclosed herein.